Future directions for cardiovascular disease comparative effectiveness research: Report of a workshop sponsored by the national heart, lung, and blood institute

Journal of the American College of Cardiology

Volumn 60, Issue 7, 2012, Pages 569-580

  Hlatky, Mark A ^a   Douglas, Pamela S ^b   Cook, Nakela L ^c   Wells, Barbara ^c   Benjamin, Emelia J ^d   Dickersin, Kay ^e   Goff, David C ^f   Hirsch, Alan T ^g   Hylek, Elaine M ^d   Peterson, Eric D ^b   Roger, Véronique L ^h   Selby, Joseph V ⁱ   Udelson, James E ^j   Lauer, Michael S ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^g UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^h MAYO CLINIC   (United States)

ⁱ DIVISION OF RESEARCH   (United States)

^j TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

clinical trials; comparative effectiveness; research methods

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

AGE DISTRIBUTION; ANTICOAGULANT THERAPY; CARDIOVASCULAR DISEASE; CATHETER ABLATION; CLAUDICATION; CLINICAL EVALUATION; CLINICAL PRACTICE; CLINICAL STUDY; COMORBIDITY; COMPARATIVE EFFECTIVENESS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONCEPTUAL FRAMEWORK; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DATA ANALYSIS; DIABETES MELLITUS; DISEASE REGISTRY; EXERCISE; EXPERIMENTAL THERAPY; FIBRINOLYTIC THERAPY; FUNDING; HEALTH CARE; HEALTH STATUS; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL DECISION MAKING; MEDICAL RESEARCH; MEDICAL SOCIETY; METHODOLOGY; OBSERVATIONAL METHOD; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROCESS MODEL; RESEARCH PRIORITY; RESOURCE ALLOCATION; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SMOKING CESSATION; STUDY DESIGN;

CARDIOVASCULAR DISEASES; EVIDENCE-BASED MEDICINE; HUMANS; INSTITUTE OF MEDICINE (U.S.); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; UNITED STATES;

EID: 84864720888     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.12.057     Document Type: Review

References (39)

1. IOM (Institute of Medicine) Initial National Priorities for Comparative Effectiveness Research 2009 The National Academies Press Washington, DC
2. J. Concato, P. Peduzzi, G. Huang, T.J. O'Leary, J. Kupersmith Comparative effectiveness research: what kind of studies do we need? J Investig Med 58 2010 764 769
3. The ACCORD Study Group Long-term effects of intensive glucose lowering on cardiovascular outcomes N Engl J Med 364 2011 818 828
4. D.G. Wyse, A.L. Waldo, J.P. DiMarco AFFIRM Investigators A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
5. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2002 2981 2997
6. The BARI Investigators The final 10-year follow-up results from the BARI randomized trial J Am Coll Cardiol 49 2007 1600 1606
7. The BARI 2D Study Group A randomized trial of therapies for type 2 diabetes and coronary artery disease N Engl J Med 360 2009 2503 2515
8. E.L. Alderman, M.G. Bourassa, L.S. Cohen Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study Circulation 82 1990 1629 1646
9. S.B. King, A.S. Kosinski, R.A. Guyton, N.J. Lembo, W.S. Weintraub Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST) J Am Coll Cardiol 35 2000 1116 1121
10. J.S. Hochman, G.A. Lamas, C.E. Buller Occluded Artery Trial Investigators Coronary intervention for persistent occlusion after myocardial infarction N Engl J Med 355 2006 2395 2407
11. G.H. Bardy, K.L. Lee, D.B. Mark SCD-HeFT Investigators Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
12. E.J. Velazquez, K.L. Lee, M.A. Deja STICH Investigators Coronary-artery bypass surgery in patients with left ventricular dysfunction N Engl J Med 364 2011 1607 1616
13. J.E. Manson, J. Hsia, K.C. Johnson Women's Health Initiative Investigators Estrogen plus progestin and the risk of coronary heart disease N Engl J Med 349 2003 523 534
14. W.O. Myers, E.H. Blackstone, K. Davis, E.D. Foster, G.C. Kaiser CASS Registry long term surgical survival: Coronary Artery Surgery Study J Am Coll Cardiol 33 1999 488 498
15. W.A. Ray Evaluating medication effects outside of clinical trials: new-user designs Am J Epidemiol 158 2003 915 920
16. P.R. Rosenbaum, D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1983 41 55
17. R.J. Glynn, S. Schneeweiss, T. Stürmer Indications for propensity scores and review of their use in pharmacoepidemiology Basic Clin Pharmacol Toxicol 98 2006 253 259
18. J.M. Robins, M.A. Hernán, B. Brumback Marginal structural models and causal inference in epidemiology Epidemiology 11 2000 550 560
19. J.P. Newhouse, M. McClellan Econometrics in outcomes research: the use of instrumental variables Annu Rev Public Health 19 1998 17 34
20. J.V. Selby, B.H. Fireman, R.J. Lundstrom Variation among hospitals in coronary angiography practices and outcomes after myocardial infarction in a large health maintenance organization N Engl J Med 335 1996 1888 1896
21. S.C. Johnston, T. Henneman, C.E. McCulloch, M. van der Lann Modeling treatment effects on binary outcomes with grouped-treatment variables and individual covariates Am J Epidemiol 156 2002 753 760
22. K. Dickersin To reform U.S. health care, start with systematic reviews Science 329 2010 516 517
23. E.M. Antman, J. Lau, B. Kupelnick, F. Mosteller, T.C. Chalmers A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts: treatments for myocardial infarction JAMA 268 1992 240 248
24. D.M. Caldwell, A.E. Ades, J.P. Higgins Simultaneous comparison of multiple treatments: combining direct and indirect evidence BMJ 331 2005 897 900
25. A. Go, E.M. Hylek, K.A. Phillips Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study JAMA 285 2001 2370 2375
26. J.D. Douketis, P.B. Berger, A.S. Dunn The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition) Chest 133 2008 299 339
27. T.P. Murphy, A.T. Hirsch, J.J. Ricotta CLEVER Steering Committee The CLaudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods J Vasc Surg 47 2008 1356 1363
28. The CASS Investigators Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery Survival data Circulation 68 1983 939 950
29. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease N Engl J Med 335 1996 217 225
30. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
31. S. Eldridge, D. Ashby, C. Bennett, M. Wakelin, G. Feder Internal and external validity of cluster randomised trials: systematic review of recent trials BMJ 336 2008 876 880
32. B.R. Luce, J.M. Kramer, S.N. Goodman Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change Ann Intern Med 151 2009 206 209
33. The Action to Control Cardiovascular Risk in Diabetes Study Group Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2008 2545 2559
34. The ADVANCE Collaborative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2008 2560 2572
35. W. Duckworth, C. Abraira, T. Moritz VADT Investigators Glucose control and vascular complications in veterans with type 2 diabetes N Engl J Med 360 2009 129 139
36. P. Gæde, H. Lund-Andersen, H.H. Parving, O. Pedersen Effect of a multifactorial intervention on mortality in type 2 diabetes N Engl J Med 358 2008 580 591
37. P. Greenland, J.S. Alpert, G.A. Beller 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 56 2010 e50 e103
38. G. Mowatt, E. Cummins, N. Waugh Systematic review of the clinical effectiveness and cost-effectiveness of 64-slice or higher computed tomography angiography as an alternative to invasive coronary angiography in the investigation of coronary artery disease Health Technol Assess 12 2008 iii iv ix-143
39. D.B. Mark, D.S. Berman, M.J. Budoff ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents J Am Coll Cardiol 55 2010 2663 2699